Cancer

INDICATION: Leukemia; multiple myeloma (MM)

Cell studies identified a dual HDAC6/proteasome inhibitor that could help treat

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE